The effect of the routine use of novobiocin and spiramycin in combination on the antibiotic sensitiveness of hospital Staphylococci.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D006761:Hospitals; D008837:Micrococcus / Q000472:pathogenicity* / Q000628:therapy*; D009675:Novobiocin; D015572:Spiramycin; D013210:Staphylococcus
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D009675:Novobiocin; D015572:Spiramycin
ANTIBIOTICS/therapeutic use; MICROCOCCAL INFECTIONS/therapy